Sunbelt Securities’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20
Closed -$525 3008
2025
Q4
$525 Hold
20
﹤0.01% 2232
2025
Q3
$452 Hold
20
﹤0.01% 2245
2025
Q2
$369 Hold
20
﹤0.01% 1727
2025
Q1
$338 Hold
20
﹤0.01% 1725
2024
Q4
$368 Hold
20
﹤0.01% 1732
2024
Q3
$435 Hold
20
﹤0.01% 1748
2024
Q2
$392 Hold
20
﹤0.01% 1669
2024
Q1
$434 Hold
20
﹤0.01% 1637
2023
Q4
$578 Hold
20
﹤0.01% 1587
2023
Q3
$535 Buy
+20
New +$683 ﹤0.01% 1647
2023
Q2
Sell
-200
Closed -$5.94K 1714
2023
Q1
$5.94K Buy
+200
New +$6.44K ﹤0.01% 1257

Other funds holding FLGT

Sunbelt Securities's FLGT Position: Q1 2026 in Review

Sunbelt Securities sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 20 shares — an estimated $525 sold.

Sunbelt Securities first reported a position in FLGT in Q1 2023 and held it in 11 quarters. The position peaked at $5.94K in Q1 2023. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Sunbelt Securities reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Sunbelt Securities sold 20 Fulgent Genetics shares in Q1 2026, an estimated $525.
  • Sunbelt Securities first reported a position in Fulgent Genetics in Q1 2023 and held it in 11 quarters.
  • Sunbelt Securities's Fulgent Genetics position peaked at $5.94K in Q1 2023.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.